CLINICAL_TRIALS
trial_result
· 2024-11-05
Clinical Trial Update: Induction Optimization With Stelara for Crohn's Disease [Phase 4]
Summary
A Phase 4 trial evaluating induction optimization with ustekinumab (Stelara) for Crohn's disease was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Crohn Disease | Phase 4 | Status: TERMINATED | Results posted: 2024-11-05